# Proteomic and Inflammatory Omics Changes With Colchicine Therapy in Coronary Heart Disease

> **NCT07462325** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Chinese Academy of Medical Sciences, Fuwai Hospital** · enrollment: 176 (estimated)

## Conditions studied

- Coronary Heart Disease (CHD)

## Interventions

- **DRUG:** colchicine

## Key facts

- **NCT ID:** NCT07462325
- **Lead sponsor:** Chinese Academy of Medical Sciences, Fuwai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 176 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07462325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07462325, "Proteomic and Inflammatory Omics Changes With Colchicine Therapy in Coronary Heart Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07462325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*